MCP
NTUS

Mirador Capital Partners’s Natus Medical Inc NTUS Stock Holding History

Mirador Capital Partners’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,475
Closed -$1.33M – 204
2022
Q2 		$1.33M Sell
40,475
-30,968
-43% -$979K 0.31% 63
2022
Q1 		$1.88M Buy
71,443
+1,535
+2% +$37.5K 0.38% 61
2021
Q4 		$1.66M Buy
69,908
+8,842
+14% +$218K 0.35% 68
2021
Q3 		$1.53M Buy
61,066
+4,040
+7% +$103K 0.35% 70
2021
Q2 		$1.48M Buy
57,026
+209
+0.4% +$5.69K 0.34% 74
2021
Q1 		$1.46M Buy
56,817
+16,768
+42% +$430K 0.37% 73
2020
Q4 		$803K Buy
40,049
+3,041
+8% +$59.6K 0.22% 98
2020
Q3 		$634K Buy
37,008
+17,275
+88% +$327K 0.2% 100
2020
Q2 		$431K Buy
19,733
+1,286
+7% +$29.4K 0.16% 98
2020
Q1 		$427K Sell
18,447
-4,004
-18% -$116K 0.18% 89
2019
Q4 		$741K Buy
22,451
+493
+2% +$15.8K 0.3% 80
2019
Q3 		$699K Buy
21,958
+10,223
+87% +$298K 0.31% 78
2019
Q2 		$301K Buy
11,735
+1,258
+12% +$32.1K 0.15% 115
2019
Q1 		$266K Buy
10,477
+2,097
+25% +$62.6K 0.14% 117
2018
Q4 		$285K Sell
8,380
-954
-10% -$31K 0.18% 102
2018
Q3 		$333K Buy
9,334
+2,063
+28% +$72.8K 0.16% 110
2018
Q2 		$251K Sell
7,271
-251
-3% -$8.8K 0.14% 120
2018
Q1 		$249K Sell
7,522
-41,447
-85% -$1.31M 0.17% 104
2017
Q4 		$1.87M Sell
48,969
-451
-0.9% -$18K 1.02% 36
2017
Q3 		$1.89M Buy
49,420
+868
+2% +$30.6K 1.11% 31
2017
Q2 		$1.69M Buy
48,552
+17,618
+57% +$636K 1.04% 31
2017
Q1 		$1.21M Buy
30,934
+3,127
+11% +$117K 0.88% 38
2016
Q4 		$968K Sell
27,807
-108
-0.4% -$4.24K 0.78% 44
2016
Q3 		$1.1M Buy
27,915
+20,870
+296% +$832K 0.96% 42
2016
Q2 		$271K Buy
+7,045
New +$236K 0.27% 84

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirador Capital Partners's NTUS Position: Q3 2022 in Review

Mirador Capital Partners sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 40,475 shares — an estimated $1.33M sold.

Mirador Capital Partners first reported a position in NTUS in Q2 2016 and held it in 25 quarters. The position peaked at $1.89M in Q3 2017. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Mirador Capital Partners reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Mirador Capital Partners sold 40,475 Natus Medical Inc shares in Q3 2022, an estimated $1.33M.
  • Mirador Capital Partners first reported a position in Natus Medical Inc in Q2 2016 and held it in 25 quarters.
  • Mirador Capital Partners's Natus Medical Inc position peaked at $1.89M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Mirador Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.